glp-1 fill finish cdmo CDMO/CMO Outlook: Fill-Finish: A Capacity Crunch or Capacity Easing? CDMO player OneSource expands GLP-1

Pinheiro MM, de Souza LG, Nunes GP, et al

Yes, gastrointestinal side effects including gas, bloating, and flatulence can occur with GLP-1 receptor agonist therapy

When the body is deficient in carnitine, long-chain fatty acids cannot be efficiently transported into the mitochondria for beta-oxidation

Synergetic Tissue Research

lncRNA PICSAR alters cell proliferation, migration, invasion, IL-6, IL-8, and MMP-3 production through sponging miR-4701-5p, in other words, lncRNA PICSAR can competitively combine miR-4701-5p to affect downstream target genes (257)

Advance Reproducible Peptide Research With Precision Solutions From Prime Lab Peptides Researchers frequently encounter variability in peptide sourcing, incomplete analytical characterization, batch inconsistency, and limited receptor-binding validation data